EGFR and astrocytoma (excluding glioblastoma): We considered the possibility that excessive genomic instability may have led to EGFR amplification in our cases and therefore also tested the four cases on a classifier that includes primary mismatch repair-deficient IDH-mutant astrocytomas (PMMRDIA) as a separate category.